The FDA granted full approval to the menin inhibitor revumenib (Revuforj) for adults and children 1 year and older with relapsed/refractory acute leukemia and a lysine methyltransferase 2A gene ( ...

ALL patients who received Aucatzyl immunotherapy, made from their own T cells, experienced complete remission within three ...

The CAR-T cell therapy Aucatzyl was approved for relapsed or refractory B-cell precursor acute lymphoblastic leukemia based ...

The immune system and especially the B cells of patients with acute lymphoblastic leukemia (ALL) is severely compromised following withdrawal from therapy, according to a new study. However, 6 months ...

The FDA is set to decide on four promising therapies in the next two weeks, including a CAR T for acute lymphoblastic ...

leading to symptoms like fevers, night sweats, and weight loss. B-PLL tends to be more aggressive than other types of leukemia and carries a less favorable outlook. Keep reading to learn more ...

The FDA has granted accelerated approval to asciminib as a first-line treatment for adults newly diagnosed with Philadelphia chromosome-positive chronic myeloid leukemia, a rare type of blood cancer.

a 7-year-old boy who is battling T-Cell Acute Lymphoblastic Leukemia. They collected $5,000 to help the family cover medical expenses. To view our latest e-Edition click the image on the left.

For children with acute lymphoblastic leukemia (ALL), measurable residual disease (MRD) after the end of first consolidation (EOC) can be used to predict the need for subsequent MRD measurements ...

Symptoms of chronic myelomonocytic leukemia (CMML) can include tiredness, bruising and bleeding easily, frequent infections, sweating, and bone pain. Symptoms can depend on the type of CMML.

A high level of lymphocytes (white blood cells that recognize something as foreign to the body) can be an indication of leukemia in dogs, according to VCA Animal Hospitals. Due to this discovery, ...